Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. López-Longo
OP0142 Rituximab in Systemic Sclerosis : Safety and Efficacy Data From the Eustar Network
Related publications
Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
Journal of Immunology Research
Medicine
Allergy
Immunology
Erratum to “Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients From a Single Centre Cohort: A EUSTAR Registration Initiative”
Acta Medica Portuguesa
Medicine
Efficacy and Safety of Rituximab for Systemic Lupus Erythematosus-Associated Immune Cytopenias. A Multicenter Retrospective Cohort Study of 71 Adults
American Journal of Hematology
Hematology
Effects of Treatment With Rituximab on Microcirculation in Patients With Long-Term Systemic Sclerosis
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Predictors of Disease Worsening Defined by Progression of Organ Damage in Diffuse Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Classification, Categorization and Essential Items for Digital Ulcer Evaluation in Systemic Sclerosis: A DeSScipher/European Scleroderma Trials and Research Group (EUSTAR) Survey
Arthritis Research & Therapy
Efficacy and Safety of Rituximab in Hepatitis-B Virus-Associated PLA2R-positive Membranous Nephropathy
Kidney International Reports
Nephrology
Systemic Sclerosis and Malignancy: A Review of Current Data
Journal of Clinical Medicine Research
Estimating Benefits From Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data From the Canadian Scleroderma Research Group
Open Journal of Rheumatology and Autoimmune Diseases
